|
| Press Releases |
|
 |
|
| Wednesday, August 24, 2022 |
|
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Friday, July 8, 2022 |
|
|
SinoMab Received the Highest Subsidy from HKSTP |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-listed biopharmaceutical company dedicated to the research, development more info >> |
|
|
中国抗体获香港科学园最高专项补贴 |
| 中国抗体制药有限公司（“中国抗体”或“公司”，连同其附属公司，统称“集团”；股份代号：3681.HK），一家专注于研究、开发、制造及商业化免疫疾病创新疗法的香港生物制药上市公司，主要研制以单克隆抗体为基础的生物药，欣然宣布公司获得香港科技园公司（“香港科学园”）800万港元专项补贴。 more info >> |
|
|
中國抗體獲香港科學園最高專項補貼 |
| 中國抗體製藥有限公司（「中國抗體」或「公司」，連同其附屬公司，統稱「集團」；股份代號：3681.HK），一家專注於研究、開發、製造及商業化免疫疾病創新療法的香港生物製藥上市公司，主要研製以單克隆抗體為基礎的生物藥，欣然宣佈公司獲得香港科技園公司（「香港科學園」）800萬港元專項補貼。 more info >> |
|
| Tuesday, June 21, 2022 |
|
|
中国抗体的旗舰产品舒西利单抗SM03的作用机理在美国免疫领域权威期刊the Journal of Immunology上成功发表 |
| 中国抗体制药有限公司（“中国抗体”或“公司”，连同其附属公司，统称“集团”；股份代号：3681.HK），一家专注于研究、开发、制造及商业化免疫疾病创新疗法的香港生物制药上市公司，主要研制以单克隆抗体为基础的生物药，欣然宣布 more info >> |
|
|
中國抗體的旗艦產品舒西利單抗SM03的作用機理在美國免疫領域權威期刊the Journal of Immunology上成功發表 |
| 中國抗體製藥有限公司（「中國抗體」或「公司」，連同其附屬公司，統稱「集團」；股份代號：3681.HK），一家專注於研究、開發、製造及商業化免疫疾病創新療法的香港生物製藥上市公司，主要研製以單克隆抗體為基礎的生物藥 more info >> |
|
|
The Mechanism of Action of SinoMab's Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S. |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-listed biopharmaceutical company dedicated to the research, development more info >> |
|
| Wednesday, June 15, 2022 |
|
|
中国抗体在美国完成SM17 I期临床试验首例健康受试者给药 |
| 中国抗体制药有限公司（“中国抗体”或“公司”，连同其附属公司，统称“集团”；股份代号：3681.HK），专注研究、开发、制造及商业化免疫性疾病疗法的香港生物制药公司，欣然宣布，其一类新药（First-in-Class）SM17（注射用人源化抗IL-17RB单克隆抗体）在美国完成其I期临床试验之首例健康受试者给药，目前受试者情况正常。 more info >> |
|
|
中國抗體在美國完成SM17 I期臨床試驗首例健康受試者給藥 |
| 中國抗體製藥有限公司（「中國抗體」或「公司」，連同其附屬公司，統稱「集團」；股份代號：3681.HK），專注研究、開發、製造及商業化免疫性疾病療法的香港生物製藥公司，欣然宣佈，其一類新藥（First-in-Class）SM17（注射用人源化抗IL-17RB單克隆抗體）在美國完成其I期臨床試驗之首例健康受試者給藥，目前受試者情況正常。 more info >> |
|
|
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S. |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TOYOTA、役員人事および幹部職人事について発表
Mar 22, 2023 17:00: JST
|
|
|
富士通、女性活躍に優れた企業として「なでしこ銘柄」に選定
Mar 22, 2023 16:30: JST
|
|
|
Fujitsu named a "Nadeshiko Brand" company for promoting women's success
Mar 22, 2023 16:45 JST
|
|
|
VueReal Inc. Announces the Appointment of Kevin Soukup, a Semiconductor Industry Veteran, as a Member of the Board of Directors
Mar 22, 2023 14:00 HKT/SGT
|
|
|
EveLab Insight Releases Latest Product Feature - Glow Detection, Helping Beauty Businesses Upgrade Personalized Skincare Solutions Through AI Skin Analysis System
Mar 22, 2023 13:00 HKT/SGT
|
|
|
マツダ、2023年度のモータースポーツ協賛について発表
Mar 22, 2023 13:00: JST
|
|
|
三菱自、『MITSUBISHI XRT Concept』を第44回バンコク国際モーターショー2023に参考出品
Mar 22, 2023 12:00: JST
|
|
|
Freedom Business Summit 2023 brings together 5000+ entrepreneurs, freedom seekers and global citizens from all over the world
Mar 22, 2023 09:13: JST
|
|
|
Infocus International Relaunches Online Workshop on Human Capital, Succession Planning, Talent & Performance Management
Mar 22, 2023 09:00: JST
|
|
|
金山软件公布2022年全年及第四季度业绩
Mar 22, 2023 09:00 HKT/SGT
|
|
|
金山軟件公佈2022年全年及第四季度業績
Mar 22, 2023 08:59 HKT/SGT
|
|
|
Kingsoft Announces 2022 Annual and Fourth Quarter Results
Mar 22, 2023 08:58 HKT/SGT
|
|
|
Freedom Business Summit 2023 brings together 5000+ entrepreneurs, freedom seekers and global citizens from all over the world
Mar 22, 2023 08:13 HKT/SGT
|
|
|
Infocus International Relaunches Online Workshop on Human Capital, Succession Planning, Talent & Performance Management
Mar 22, 2023 08:00 HKT/SGT
|
|
|
Tradition Meets Innovation - A Digital Certificate for Authentic Italian Products
Mar 21, 2023 22:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
